| Literature DB >> 33710362 |
Barbara Obermayer-Pietsch1, Ines Fössl2, Hans Peter Dimai2.
Abstract
The need for a long-term pharmacological treatment of osteoporosis, the problem of potential compliance issues and also potentially severe side effects during the treatment are of central interest not only for patients but also for medical guidelines and prescribers. This review summarizes the current knowledge about the pharmacological substances used and the current scientifically based guidelines and approaches for the long-term use as well as the monitoring and potential treatment changes with a special focus on future developments.Entities:
Keywords: Compliance; Drug-related side effects and adverse reactions; Patient monitoring; Pharmaceuticals; Research and development
Year: 2021 PMID: 33710362 DOI: 10.1007/s00108-021-00993-3
Source DB: PubMed Journal: Internist (Berl) ISSN: 0020-9554 Impact factor: 0.743